Literature DB >> 24556347

Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis.

J Castilla1, I Martínez-Baz, A Navascués, M Fernandez-Alonso, G Reina, M Guevara, J Chamorro, M T Ortega, E Albéniz, F Pozo, C Ezpeleta.   

Abstract

We estimate mid-2013/14 season vaccine effectiveness (VE) of the influenza trivalent vaccine in Navarre, Spain. Influenza-like illness cases attended in hospital (n=431) and primary healthcare (n=344) were included. The overall adjusted VE in preventing laboratory-confirmed influenza was 24% (95% CI: -14 to 50). The VE was 40% (95% CI: -12 to 68) against influenza A(H1)pdm09 and 13% (95% CI: -36 to 45) against influenza A(H3). These results suggest a moderate preventive effect against influenza A(H1)pdm09 and low protection against influenza A(H3).

Mesh：

Substances：

Year:  2014        PMID： 24556347     DOI： 10.2807/1560-7917.es2014.19.6.20700

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  9 in total

1.  On the bias of estimates of influenza vaccine effectiveness from test-negative studies.

Authors:  Kylie E C Ainslie; Meng Shi; Michael Haber; Walter A Orenstein
Journal:  Vaccine       Date:  2017-11-13       Impact factor: 3.641

2.  Influenza vaccine prevents medically attended influenza-associated acute respiratory illness in adults aged ≥50 years.

Authors:  Qingxia Chen; Marie R Griffin; Hui Nian; Yuwei Zhu; John V Williams; Kathryn M Edwards; H Keipp Talbot
Journal:  J Infect Dis       Date:  2014-10-21       Impact factor: 5.226

3.  Influenza vaccine effectiveness assessment through sentinel virological data in three post-pandemic seasons.

Authors:  Núria Torner; Ana Martínez; Luca Basile; M Angeles Marcos; Andrés Antón; M Mar Mosquera; Ricard Isanta; Carmen Cabezas; Mireia Jané; Angela Domínguez; The Pidirac Sentinel Surveillance Program Of Catalonia
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

4.  Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.

Authors:  M Rondy; J Castilla; O Launay; S Costanzo; C Ezpeleta; F Galtier; K de Gaetano Donati; A Moren
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

5.  Evaluation of influenza vaccine effectiveness and description of circulating strains in outpatient settings in South Africa, 2014.

Authors:  Johanna M McAnerney; Florette Treurnicht; Sibongile Walaza; Adam L Cohen; Stefano Tempia; Senzo Mtshali; Amelia Buys; Lucille Blumberg; Cheryl Cohen
Journal:  Influenza Other Respir Viruses       Date:  2015-07       Impact factor: 4.380

6.  Guidance for practitioners on the use of antiviral drugs to control influenza outbreaks in long-term care facilities in Canada, 2014-2015 season.

Authors:  Fred Y Aoki; Upton D Allen; H Grant Stiver; Michel Laverdière; Danuta Skowronski; Gerald A Evans
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Jan-Feb       Impact factor: 2.471

7.  Influenza vaccine effectiveness among high-risk groups: A systematic literature review and meta-analysis of case-control and cohort studies.

Authors:  Vincenzo Restivo; Claudio Costantino; Stefania Bono; Marialuisa Maniglia; Valentina Marchese; Gianmarco Ventura; Alessandra Casuccio; Fabio Tramuto; Francesco Vitale
Journal:  Hum Vaccin Immunother       Date:  2017-06-16       Impact factor: 3.452

8.  Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 season.

Authors:  Xi Li; Michael W Deem
Journal:  Protein Eng Des Sel       Date:  2016-06-16       Impact factor: 1.650

9.  The effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: a multicentre case-control study, Spain, 2013/14 and 2014/15.

Authors:  Angela Domínguez; Núria Soldevila; Diana Toledo; Pere Godoy; Elena Espejo; Maria Amelia Fernandez; José María Mayoral; Jesús Castilla; Mikel Egurrola; Sonia Tamames; Jenaro Astray; María Morales-Suárez-Varela
Journal:  Euro Surveill       Date:  2017-08-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.